|

TI-0032-III injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Therorna1

Indications

  • Sjogren's Syndrome (SS)1
  • ANCA Associated Systemic Vasculitis1
  • Inflammatory Myopathy1
  • Systemic Sclerosis (SSc)1
  • Systemic Lupus Erythematosus (SLE)1

Other1 trial

A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.